A carregar...
ACTR-08. A PHASE II STUDY OF APATINIB PLUS TEMOZOLOMIDE IN ADULTS WITH REFRACTORY RECURRENT HIGH-GRADE GLIOMAS
BACKGROUND: There is no standard therapy for refractory recurrent high-grade gliomas. We assessed the efficacy and safety of apatinib, a new oral small-molecule tyrosine kinase inhibitor targeted vascular endothelial growth factor receptor 2, combined with temozolomide (TMZ) in patients with refract...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216160/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.043 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|